Gene · 6504
Papers3,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell Function. | Hemasphere | 2023 | 36874381 | PubTator, text mining | PubMed |
| Infection of Pro- and Anti-Inflammatory Macrophages by Wild Type and Vaccine Strains of Measles Virus: NLRP3 Inflammasome Activation Independent of Virus Production. | Viruses | 2023 | 36851476 | PubTator, text mining | PubMed |
| sSLAM: Speeded-Up Visual SLAM Mixing Artificial Markers and Temporary Keypoints. | Sensors (Basel) | 2023 | 36850807 | PubTator, text mining | PubMed |
| Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review. | Nutrients | 2023 | 36839394 | PubTator, text mining | PubMed |
| Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL). | Int J Mol Sci | 2023 | 36835271 | PubTator, text mining | PubMed |
| Viruses Binding to Host Receptors Interacts with Autophagy. | Int J Mol Sci | 2023 | 36834833 | PubTator, text mining | PubMed |
| The Genetic and Immunologic Landscape Underlying the Risk of Malignant Progression in Laryngeal Dysplasia. | Cancers (Basel) | 2023 | 36831458 | PubTator, text mining | PubMed |
| Molecular Modeling Identification of Key Secondary Metabolites from Xylopia aethiopica as Promising Therapeutics Targeting Essential Measles Viral Proteins. | Evid Based Complement Alternat Med | 2023 | 36818222 | PubTator, text mining | PubMed |
| Bionic Path Planning Fusing Episodic Memory Based on RatSLAM. | Biomimetics (Basel) | 2023 | 36810390 | PubTator, text mining | PubMed |
| Identification of molecular subtypes of ischaemic stroke based on immune-related genes and weighted co-expression network analysis. | IET Syst Biol | 2023 | 36802116 | PubTator, text mining | PubMed |
| Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment. | Sci Rep | 2023 | 36801909 | PubTator, text mining | PubMed |
| Reported History of Measles and Long-term Impact on Tetanus Antibody Detected in Children 9-59 Months of Age and Receiving 3 Doses of Tetanus Vaccine in the Democratic Republic of the Congo. | Pediatr Infect Dis J | 2023 | 36795582 | PubTator, text mining | PubMed |
| Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment. | AIDS | 2023 | 36779490 | PubTator, text mining | PubMed |
| A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors. | Cell Death Dis | 2023 | 36765035 | PubTator, text mining | PubMed |
| The Integrator complex regulates microRNA abundance through RISC loading. | Sci Adv | 2023 | 36763664 | PubTator, text mining | PubMed |
| Immune Mechanisms in Inflammatory Anemia. | Annu Rev Immunol | 2023 | 36750316 | PubTator, text mining | PubMed |
| Chikungunya virus entry and infectivity is primarily facilitated through cell line dependent attachment factors in mammalian and mosquito cells. | Front Cell Dev Biol | 2023 | 36743418 | PubTator, text mining | PubMed |
| Association of IFN-γ +874 A/T SNP and hypermethylation of the -53 CpG site with tuberculosis susceptibility. | Front Cell Infect Microbiol | 2023 | 36743307 | PubTator, text mining | PubMed |
| NK cell education: Physiological and pathological influences. | Front Immunol | 2023 | 36742337 | PubTator, text mining | PubMed |
| Resolving the hematopoietic stem cell state by linking functional and molecular assays. | Blood | 2023 | 36735913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6504/papers?page=23